JP2024511079A5 - - Google Patents
Info
- Publication number
- JP2024511079A5 JP2024511079A5 JP2023557734A JP2023557734A JP2024511079A5 JP 2024511079 A5 JP2024511079 A5 JP 2024511079A5 JP 2023557734 A JP2023557734 A JP 2023557734A JP 2023557734 A JP2023557734 A JP 2023557734A JP 2024511079 A5 JP2024511079 A5 JP 2024511079A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- composition according
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163161758P | 2021-03-16 | 2021-03-16 | |
| US63/161,758 | 2021-03-16 | ||
| PCT/US2022/020385 WO2022197703A1 (en) | 2021-03-16 | 2022-03-15 | Wound healing enhancement with anti-ceramide antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511079A JP2024511079A (ja) | 2024-03-12 |
| JP2024511079A5 true JP2024511079A5 (cg-RX-API-DMAC7.html) | 2025-09-03 |
Family
ID=83321040
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023557734A Pending JP2024511079A (ja) | 2021-03-16 | 2022-03-15 | 抗セラミド抗体による創傷治癒の強化 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240158487A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4308231A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511079A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230162788A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117320750A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023018758A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3212333A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL305920A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010858A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022197703A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12655229B2 (en) | 2020-03-18 | 2026-06-16 | Memorial Sloan Kettering Cancer Center | Anti-ceramide antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2152287B1 (en) * | 2007-05-06 | 2014-04-02 | Sloan Kettering Institute For Cancer Research | Methods for treating and preventing gi syndrome and graft versus host disease |
| US8129341B2 (en) * | 2008-08-25 | 2012-03-06 | New York University | Methods for treating diabetic wounds |
| US10722577B2 (en) * | 2012-05-25 | 2020-07-28 | Sloan Kettering Institute For Cancer Research | Methods for treating GI syndrome and graft versus host disease |
| SG11201700787XA (en) * | 2014-08-07 | 2017-02-27 | Sloan Kettering Inst Cancer | Anti-ceramide antibodies |
| US12655229B2 (en) * | 2020-03-18 | 2026-06-16 | Memorial Sloan Kettering Cancer Center | Anti-ceramide antibodies |
-
2022
- 2022-03-15 BR BR112023018758A patent/BR112023018758A2/pt unknown
- 2022-03-15 KR KR1020237035170A patent/KR20230162788A/ko active Pending
- 2022-03-15 CA CA3212333A patent/CA3212333A1/en active Pending
- 2022-03-15 CN CN202280032286.4A patent/CN117320750A/zh active Pending
- 2022-03-15 US US18/550,933 patent/US20240158487A1/en active Pending
- 2022-03-15 MX MX2023010858A patent/MX2023010858A/es unknown
- 2022-03-15 JP JP2023557734A patent/JP2024511079A/ja active Pending
- 2022-03-15 EP EP22772059.6A patent/EP4308231A4/en active Pending
- 2022-03-15 WO PCT/US2022/020385 patent/WO2022197703A1/en not_active Ceased
- 2022-03-15 IL IL305920A patent/IL305920A/en unknown